Artesunate could increase survival of the severe acute pancreatitis model rats.
This effect was related to suppression of digestive enzyme and pro-inflammatory cytokines.
The mechanism may be related to inhibition the LPS-TLR4/NF-κB signaling pathway.
Artesunate could be considered as a possible effective therapeutic agent for acute pancreatitis.